ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Senate Bill Would Require Clinical Trials To Test Gender, Racial Differences In Therapies

August 10, 1990

NCI-Approved Clinical Trials

July 30, 2004

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

In Brief: Schmidt Confers With Califano, Fredrickson On NCI director; Senate Hearing March 15-16

February 18, 1977

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000